Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PP2A-β Activators

PP2A-β Activators comprise a select group of chemical compounds that indirectly augment the functional activity of PP2A-β through various intracellular mechanisms, primarily by inhibiting the activity of competing phosphatases. Fostriecin, Cantharidin, Okadaic Acid, Calyculin A, Endothall, Microcystin-LR, Tautomycin, Norcantharidin, Phenothiazines, Rubratoxin B, and LB-100 all function by selectively inhibiting serine/threonine phosphatases that compete with PP2A-β, ensuring that PP2A-β retains a larger pool of substrates for its dephosphorylation actions, thus indirectly enhancing its activity. These inhibitors, while themselves not acting directly on PP2A-β, create a biochemical environment that favors PP2A-β's activity through the reduction of its competitors' influence, effectively shifting the cellular equilibrium towards the pathways PP2A-β regulates such as cell cycle control, apoptosis, and DNA damage repair.

Additionally, some compounds like Ionomycin exert their effects by modulating intracellular calcium levels, which can promote PP2A-β activity through calcium-dependent signaling mechanisms. The alteration of calcium homeostasis by Ionomycin may lead to the activation of calcium-sensitive enzymes and proteins that work in concert with PP2A-β, enhancing its role in cellular signaling pathways. Collectively, these PP2A-β Activators, through their targeted biochemical actions, facilitate the enhancement of PP2PP2A-β Activators encompass a range of chemical compounds that indirectly enhance the functional activity of PP2A-β by influencing the cellular environment and signaling pathways to favor its activity. The strategy behind activating PP2A-β involves the selective inhibition of its competitive phosphatases, thereby indirectly amplifying its role in dephosphorylation processes. Compounds such as Fostriecin, Cantharidin, and Okadaic Acid specifically target PP2A-β's competitors like PP1, diminishing their activity and consequently allowing PP2A-β to operate on a broader spectrum of substrates. This selective inhibition is also seen with Calyculin A, Endothall, and Microcystin-LR, which, by binding to and inhibiting other serine/threonine phosphatases, ensure that PP2A-β's phosphatase activity is relatively upregulated. Norcantharidin, a demethylated analog of cantharidin, and chemical classes like Phenothiazines further contribute to this effect by their preferential inhibition of other phosphatases, indirectly increasing the functional capacity of PP2A-β in cellular processes such as cell cycle regulation and signal transduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$33.00
$77.00
$120.00
14
(1)

FTY720 is phosphorylated in vivo to form FTY720-P, which acts as a sphingosine-1-phosphate receptor modulator. This leads to the activation of the PP2A-β by promoting its re-association with regulatory subunits, thereby enhancing its phosphatase activity.

C2 Ceramide

3102-57-6sc-201375
sc-201375A
5 mg
25 mg
$124.00
$460.00
12
(1)

Ceramide, a sphingolipid, acts on intracellular signaling pathways and can activate PP2A-β by altering the composition of its regulatory subunits, which can change the substrate specificity and localization, resulting in increased phosphatase activity.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, leading to an increase in cAMP levels, which indirectly enhances PP2A-β activity by promoting the dissociation of its inhibitory subunits through PKA-mediated phosphorylation events.

Cantharidin

56-25-7sc-201321
sc-201321A
25 mg
100 mg
$89.00
$279.00
6
(1)

Cantharidin inhibits PP2A-β's close relative PP1, which can result in a compensatory enhancement of PP2A-β activity to maintain overall phosphatase activity within the cell.

D-erythro-Sphingosine

123-78-4sc-3546
sc-3546A
sc-3546B
sc-3546C
sc-3546D
sc-3546E
10 mg
25 mg
100 mg
1 g
5 g
10 g
$90.00
$194.00
$510.00
$2448.00
$9384.00
$15300.00
2
(2)

D-erythro-Sphingosine functions similarly to ceramide, as it is involved in sphingolipid signaling that can modulate PP2A-β's conformation and enhance its activity by influencing the composition of its subunits.

Endothall

145-73-3sc-201325
sc-201325A
20 mg
100 mg
$49.00
$203.00
1
(1)

Endothall is a PP2A-β inhibitor, but at low concentrations, it may paradoxically enhance PP2A-β activity by stabilizing the enzyme in a conformation that favors the binding of its physiological substrates.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic acid is a well-known inhibitor of PP2A, but it can enhance PP2A-β activity at sub-inhibitory concentrations by inducing a mild stress response that results in a compensatory upregulation of PP2A-β's activity.

Phytosphingosine

554-62-1sc-201385
sc-201385A
5 mg
25 mg
$102.00
$427.00
4
(1)

Sphingosylphosphorylcholine alters the lipid environment of PP2A-β, which can modulate its activity by changing the interaction with its regulatory subunits, thereby enhancing the phosphatase activity.

Sodium selenate

13410-01-0sc-251052A
sc-251052
sc-251052B
sc-251052C
25 g
100 g
500 g
1 kg
$52.00
$187.00
$332.00
$599.00
(0)

Sodium Selenate is known to activate PP2A-β by promoting the dephosphorylation of its C subunit, which is essential for the catalytic activity of PP2A-β.

Arsenic(III) oxide

1327-53-3sc-210837
sc-210837A
250 g
1 kg
$89.00
$228.00
(0)

Arsenic trioxide has been shown to enhance PP2A-β activity by promoting the formation of PP2A-β-containing trimeric complexes, which are more active than the dimeric or monomeric forms.